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INTRODUCTION
Chronic kidney disease (CKD) is a worldwide problem,
and its prevalence is increasing dramatically. According to
data from the National Health and Nutrition Examination
Surveys (NHANES), the prevalence of CKD in the United
States was 13.1% between 1999 and 2004, which indicated
an increase compared to the 10.0% prevalence noted dur-
ing the 1994-1998 period (1). In the AusDiab kidney study,
approximately 16% of Australian adults had markers of CKD,
including proteinuria, hematuria, or reduced glomerular filtra-
tion rate (GFR) (2). The prevalence of CKD in Asia is not
lower than that seen in Western countries. The prevalence
of GFR less than 60 mL/min/1.73 m2 in the adult Japanese
population is 19.1% (3). A recent study found the prevalence
of CKD in Beijing to be 13.0% (4). 
CKD is a well known predictor of hospitalization (5), car-
diovascular events (5-8), cardiovascular mortality (5), non-
cardiac mortality (9), and all-cause mortality (5-7). Decreased
renal function is also a risk factor for cognitive dysfunction
(10) and poor quality of life (11). Some CKD-related metabol-
ic complications, such as anemia and hyperparathyroidism,
are observed early in stage 3 CKD (12). Despite the signifi-
cant health problems associated with CKD, an English study
showed that only 15.2% of patients with CKD were known
to renal services and only 8.1% of patients were referred to a
nephrologist during a mean follow-up period of 31.3 months
(13). Late referral to a nephrologist was an important risk
factor for patient mortality (13). The cost of health services
for patients with CKD is 1.8 times the cost for patients with-
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The Prevalence of Chronic Kidney Disease (CKD) and the Associated
Factors to CKD in Urban Korea: A Population-based Cross-sectional
Epidemiologic Study
Chronic kidney disease (CKD) is a worldwide problem. This study was designed to
survey the prevalence and risk factors for CKD in Korea. The 2,356 subjects were
selected in proportion to age, gender, and city. Subjects 35 yr of age or older were
selected from 7 cities. Estimated glomerular filtration rate (eGFR) was calculated
using the Modification of Diet in Renal Disease (MDRD) Study equation, with albu-
minuria defined as a urine albumin to creatinine ratio of 30 mg/g or more. The
overall prevalence of CKD was 13.7%. The prevalences of CKD according to stage
were 2.0% stage 1, 6.7% stage 2, 4.8% stage 3, 0.2% stage 4, and 0.0% stage 5.
The prevalences of microalbuminuria and macroalbuminuria were 8.6% and 1.6%,
respectively. The prevalence of eGFR less than 60 mL/min/1.73 m
2 was 5.0%. Age,
body mass index (BMI), hypertension, diabetes mellitus, systolic blood pressure
(SBP), diastolic blood pressure (DBP), and fasting blood glucose were independent
factors related to the presence of CKD. In conclusions, Korea, in which the preva-
lence of CKD is increasing, should prepare a policy for early detection and appro-
priate treatment of CKD. The present data will be helpful in taking those actions.
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Accepted : 12 January 2009out CKD. By 2010, more than 28 billion US dollars will be
paid for health services in patients with end stage renal dis-
ease (ESRD) in the United States (14). 
In Korea, the prevalence and incidence of ESRD have been
increasing since 1986, as well (15). In 2005, the incidence of
ESRD in Korea reached 173 per million population (PMP),
and the prevalence reached 900 PMP (16). An international
comparison of ESRD epidemiology showed Korea to rank
9th in ESRD prevalence (16). The health costs for kidney
disease (defined by ICD-10 codes N18.x and N19.x) made
up 3.24% of the national expenditure for health services in
Korea in 2004. 
Although the data for patients with ESRD has been entered
into the ESRD registry in the Korean Society of Nephrolo-
gy since 1986, there have been no studies detailing the nation-
wide prevalence of CKD in Korea. Thus, this cross-sectional
epidemiologic study was designed to survey the prevalence
and risk factors for CKD in the 7 major cities of Korea.
MATERIALS AND METHODS
Study population
This was a cross-sectional epidemiologic study. The sam-
ple population was made up of individuals 35 yr or older,
selected in proportion to age, gender, and city in Korea. We
decided to include 2,400 persons in the study. Seven cities
were included (Seoul, Incheon, Daejeon, Gwangju, Daegu,
Ulsan, Busan); 48.03% of Koreans age 35 yr or older live in
these cities according to the 2006 Korean Population Census.
Seoul and Incheon are located in the middle of the Korean
peninsula; Daejeon and Gwangju are in the southwest; and
Ulsan, Daegu, and Busan are in the southeast. A website was
created, and an advertisement was placed in various news-
papers for volunteers to participate in this survey. The num-
ber of participants was decided according to age, gender, and
sub-district of city (Gu). Only one person per household could
participate in this survey. The website for volunteers was
closed after the planned number of participants was recruit-
ed. There were 2,413 volunteers registered to the website.
Among these, 2,364 persons completed the questionnaires
and laboratory tests. We analyzed the data of 2,356 partici-
pants and excluded 8 persons less than 35 yr of actual age.
Measurements and definitions
The subjects came to the specified hospital(s) in each city
after overnight fasting for at least 12 hr, completed the ques-
tionnaires, and completed blood and urine tests. Baseline
demographics such as age, gender, weight (kg), height (cm),
area of residence, systolic blood pressure (SBP), and diastolic
blood pressure (DBP) and laboratory tests such as serum blood
urea nitrogen (BUN), serum creatinine (Cr), fasting serum
glucose, total cholesterol, low density lipoprotein (LDL) choles-
terol, and single voided fasting urine albumin to creatinine
ratio (mg albumin/g creatinine: UACR) were examined.
Arterial blood pressure was measured using a mercury sphyg-
momanometer after participants sat for at least 15 min in
each specified hospital. Participants reported their respective
comorbidities, such as hypertension, diabetes mellitus, coro-
nary artery disease, cerebrovascular events, and renal disease;
current smoking habits; family history of hypertension, dia-
betes mellitus, coronary artery disease, renal disease, cere-
brovascular events, or cancer; and medications for hyperten-
sion and diabetes mellitus. The serum creatinine was mea-
sured by an automatic analyzer using the Jaffe method in all
participating hospitals. Estimated GFR (eGFR) was calcu-
lated using the Modification of Diet in Renal Disease (MD-
RD) Study equation (17). 
Albuminuria was defined as a UACR of 30 mg/g or more.
Microalbuminuria was defined as a UACR ranging from 30
to 299 mg/g, and macroalbuminuria was defined as a UACR
of 300 mg/g or more. Referencing the National Kidney Foun-
dation Kidney Disease Outcomes Quality Initiative (KDOQI)
working group, CKD was defined as the presence of albu-
minuria or eGFR <60 mL/min/1.73 m2. Stages of CKD
were defined as follows: stage 1 (eGFR ≥ 90 mL/min/1.73
m2 and UACR ≥30 mg/g); stage 2 (eGFR 60-89 mL/min/
1.73 m2 and UACR ≥30 mg/g); stage 3 (eGFR 30-59 mL/
min/1.73 m2 regardless of UACR); stage 4 (eGFR 15-29 mL/
min/1.73 m2 regardless of UACR); and stage 5 (eGFR <15
mL/min/1.73 m2 regardless of UACR).
Hypertension was defined as SBP of 140 mmHg or greater,
DBP of 90 mmHg or greater, or use of antihypertensive med-
ications irrespective of BP. Diabetes mellitus was defined as
a fasting glucose of 126 mg/dL or greater or use of hypogly-
cemic agents. A history of cardiovascular events was defined
as a history of coronary arterial disease or cerebrovascular acci-
dent. Body mass index (BMI) was calculated based on weight
and height (weight [kg]/height [m2]). BMI groups were classi-
fied as less than the 10th percentile (BMI <20.7 kg/m2), 10th
to 50th percentile (BMI 20.7 to 24 kg/m2), 50th to 90th per-
centile (BMI 24.1 to 28.0 kg/m2), and greater than the 90th
percentile (BMI >28.0 kg/m2), as proposed in another study (18). 
Statistical analyses
All analyses and calculations were performed using SPSS
software (SPSS version 12.0, Chicago, IL, U.S.A.). Data are
presented as the means±SDs for continuous variables and
as proportions for categorical variables. Demographic and
clinical data were described and compared between groups.
Differences were analyzed using the chi-square test for cate-
gorical variables and the Student t test or one-way ANOVA
for continuous variables according to the number of groups.
The odds ratio (OR) between the factors and CKD was cal-
culated using logistic regression analysis with or without
S12 S. Kim, C.S. Lim, D.C. Han, et al.adjustment for age, gender, BMI, hypertension, and diabetes
mellitus, which are well known risk factors for CKD. p val-
ues less than 0.05 were considered statistically significant.
RESULTS
Characteristics of participants
The proportions of age and gender in the study group were
no different compared to those in the general populations in
each city (Table 1). Of the 2,356 participants, 1,151 (48.8%)
were male and 1,205 (51.2%) were female. The mean par-
ticipant age was 50.5±11.1 yr. The prevalences of hyper-
tension and diabetes mellitus were 35.5% and 10.1%, respec-
tively. The serum creatinine was 0.83±0.11 mg/dL in women
and 1.09±0.45 mg/dL in men; it slightly increased with
age in women (p<0.05), but it did not differ among the var-
ious age groups in men (p>0.05) (Fig. 1). The eGFR level
was 79.4±12.6 mL/min/1.73 m2 in women and 79.3±12.7
mL/min/1.73 m2 in men. The mean eGFRs in age groups,
35-44 yr, 45-54 yr, 55-64 yr, and 65 yr or more were 85.3,
80.0, 74.6, and 70.5 mL/min/1.73 m2 in females, respectively,
and 83.0, 79.3, 77.0, and 71.9 mL/min/1.73 m2, in males,
respectively. The mean eGFR level decreased with age at a
rate of 4.24 mL/min/1.73 m2/10 yr in females and at a rate of
4.08 mL/min/1.73 m2/10 yr in males (Fig. 1). The UACR level
was 24.2±115.7 mg/g (median: 5.2 mg/g) in women and
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Study population
No. of partici- 
pants
%
Characteristics
2006 population 
in 7 cities
No. of partici- 
pants
%
Total 2,356 100 11,298,320 100
Age in 2006 (yr)
35-44 833 35.4 4,077,457 36.1
45-54 768 32.6 3,648,794 32.3
55-64 432 18.3 2,061,663 18.2
65 or more 257 13.7 1,510,406 13.4
Gender
Male 1,151 48.9 5,504,445 48.7
Female 1,205 51.1 5,793,875 51.3
City
Seoul 1,055 44.8 5,023,194 44.5
Incheon 263 11.2 1,279,035 11.3
Daejeon 142 6.0 687,389 6.1
Gwangju 133 5.6 642,447 5.7
Daegu 265 11.2 1,246,987 11.0
Ulsan 107 4.5 521,744 4.6
Busan 391 16.6 1,897,524 16.8
Table 1. Comparisons of demographic characteristics of the
study population and the 2006 population in 7 Korean cities 
Fig. 1. The serum creatinine and eGFR with age in each gender.
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None Macro Micro
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Stage % No.
Kidney function
eGFR % No.
≥90 435 18.5 89.0 9.2 1.8 1 48 2.0
60-89 1,804 76.6 91.2 7.8 0.9 2 158 6.7
30-59 112 4.8 73.2 19.6 7.1 3 112 4.8
15-29 4 0.2 0.0 0.0 100.0 4 4 0.2
<15 1 0.0 0.0 0.0 100.0 5 1 0.0
Total 2,356 100.0 89.8 8.6 1.6 All 323 13.7
Table 2. Prevalence of decreased kidney function and CKD in
urban Korea
eGFR, mL/min/1.73 m
2 by MDRD equation; Micro, microalubminuria;
Macro, macroalbuminuria.
CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.26.9±132.6 mg/g (median: 3.8 mg/g) in men, with no sta-
tistical difference noted between the gender groups (p>0.05).
Prevalence of CKD
The overall prevalence of CKD was 13.7%. The prevalences
of CKD according to stage were 2.0% in stage 1, 6.7% in
stage 2, 4.8% in stage 3, 0.2% in stage 4, and 0.0% in stage
5 (Table 2). The prevalence increased remarkably with age
(Table 3). The prevalence in subjects aged 65 yr or older
(31.0%) was much higher than the prevalence in subjects
35 to 44 yr of age (8.8%) (p<0.05) (Table 3). Generally, the
prevalence of CKD did not differ according to gender, but,
in participants less than 50 yr of age, the prevalence was
higher in men (11.4% vs. 7.0%, p=0.008); in subjects 50 yr
of age or greater, the prevalence was lower in men compared
to women (15.7% vs. 21.4%, p=0.014). The frequencies of
hypertension and diabetes mellitus were higher in women
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*History of CVD: cerebrovascular disease such as coronary arterial disease and cerebrovascular accident reported by participants; BMI: less than the
10th percentile (BMI <20.7 kg/m
2), 10th to 50th percentile (BMI 20.7 to 24 kg/m
2), 50th to 90th percentile (BMI 24.1 to 28.0 kg/m
2), and greater than the
90th percentile (BMI >28.0 kg/m
2).
CKD, chronic kidney disease; CVD, cerebrovascular disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
CKD stage ≥3 CKD stage 2 CKD stage 1 All CKD No-CKD
Age (yr)
35-44  760 (91.2) 73 (8.8) 18 (2.2) 49 (5.9) 6 (0.7)
45-54 683 (88.9) 85 (11.1) 18 (2.3) 49 (6.4) 18 (2.3)
55-64 367 (85.0) 65 (15.0) 10 (2.3) 26 (6.0) 29 (6.7)
65 or more 223 (69.0) 100 (31.0) 2 (0.6) 34 (10.5) 64 (19.8)
Female 1,037 (86.1) 168 (13.9) 21 (1.7) 85 (7.1) 62 (5.1)
Male 996 (86.5) 155 (13.5) 27 (2.3) 73 (6.3) 55 (4.8)
History of CVD*, no 1,974 (86.8) 299 (13.2) 45 (2.0) 150 (6.6) 104 (4.6)
History of CVD*, yes 46 (69.7) 20 (30.3) 3 (4.5) 5 (7.6) 12 (18.2)
Current non-smoking 1,548 (86.2) 248 (13.8) 29 (1.6) 120 (6.7) 99 (5.5)
Current smoking 472 (86.9) 71 (13.1) 19 (3.5) 35 (6.4) 17 (3.1)
BMI* 
Less than 10th percentile  205 (88.4) 27 (11.6) 7 (3.0) 9 (3.9) 11 (4.7)
10th-50th percentile 813 (91.5) 76 (8.5) 10 (1.1) 38 (4.3) 28 (3.1)
50th-90th percentile 819 (83.7) 159 (16.3) 25 (2.6) 73 (7.5) 61 (6.2)
Over 90th percentile 195 (76.2) 61 (23.8) 6 (2.3) 38 (14.8) 17 (6.6)
Diabetes mellitus, absent 1,859 (88.4) 244 (11.6) 34 (1.6) 118 (5.6) 92 (4.4)
Diabetes mellitus, present 161 (68.2) 75 (31.8) 14 (5.9) 37 (15.7) 24 (10.2)
Fasting Glucose (mg/dL)
Less than 110 1,846 (88.2) 247 (11.8) 34 (1.6) 119 (5.7) 94 (4.5)
110-125 92 (78.6) 25 (21.4) 3 (2.6) 15 (12.8) 7 (6.0)
126 or more 95 (65.1) 51 (34.9) 11 (7.5) 24 (16.4) 16 (11.0)
Hypertension, no 1,367 (90.7) 140 (9.3) 21 (1.4) 73 (4.8) 46 (3.1)
Hypertension, yes 651 (78.4) 179 (21.6) 27 (3.3) 82 (9.9) 70 (8.4)
SBP (mmHg)
Less than 110  309 (90.6) 32 (9.4) 2 (0.6) 18 (5.3) 12 (3.5)
110-119 442 (92.7) 35 (7.3) 7 (1.5) 14 (2.9) 14 (2.9)
120-129 475 (89.5) 56 (10.5) 8 (1.5) 26 (4.9) 22 (4.1)
130-139 378 (84.0) 72 (16.0) 10 (2.2) 37 (8.2) 25 (5.6)
140 or more 427 (76.9) 128 (23.1) 21 (3.8) 63 (11.4) 44 (7.9)
DBP (mmHg)
Less than 70  403 (91.4) 38 (8.6) 3 (0.7) 16 (3.6) 19 (4.3)
70-79 607 (88.6) 78 (11.4) 12 (1.8) 35 (5.1) 31 (4.5)
80-89 700 (86.4) 110 (13.6) 16 (2.0) 58 (7.2) 36 (4.4)
90 or more 321 (76.8) 97 (23.2) 17 (4.1) 49 (11.7) 31 (7.4)
Cholesterol (mg/dL)
Less than 200 1,424 (87.8) 197 (12.2) 34 (2.1) 102 (6.3) 61 (3.8)
200 or more 609 (82.9) 126 (17.1) 14 (1.9) 56 (7.6) 56 (7.6)
LDL-cholesterol (mg/dL)
Less than 100 939 (87.6) 133 (12.4) 25 (2.3) 64 (6.0) 44 (4.1)
100-119 577 (87.4) 83 (12.6) 12 (1.8) 42 (6.4) 29 (4.4)
120 or more 517 (82.9) 107 (17.1) 11 (1.8) 158 (6.7) 117 (5.0)
Table 3. The prevalence of CKD in adults aged 35 yr or more in urban Koreathan they were in men according to age. The prevalence of
higher BMI (more than 90th percentile) increased in women,
but decreased in men, with age (Fig. 2). Participants with
middle range BMIs (10th to 50th percentile) showed the low-
est prevalence of CKD; higher BMIs were related to higher
CKD prevalence (p<0.05) (Table 3). The prevalence of CKD
was increased with the presence of previous cardiovascular
events, hypertension, and diabetes mellitus, and with increas-
es in SBP, DBP, serum glucose, serum cholesterol, and serum
LDL-cholesterol (p<0.05) (Table 3). 
Prevalence of albuminuria
The prevalences of albuminuria, microalbuminuria, and
macroalbuminuria were 10.2%, 8.6%, and 1.6%, respective-
ly. The prevalence of albuminuria increased with age (p<0.05)
(Table 4). Generally, the prevalence of albuminuria was no
different according to gender, but, in participants less than
50 yr of age, the prevalence was higher in men (10.6% vs.
6.5%, p=0.011). In subjects 50 yr of age or greater, the preva-
lence was lower in men compared to women (10.1% vs. 14.0%,
p=0.043). The prevalence of albuminuria was also increased
in the presence of hypertension and diabetes mellitus and
with increased SBP, DBP, and serum glucose (p<0.05). The
albuminuria prevalence was not related to smoking, previ-
ous cardiovascular events, or serum levels of cholesterol or
LDL-cholesterol (p>0.05). 
Prevalence of decreased renal function (eGFR less than
60 mL/min/1.73 m
2)
The prevalence of decreased renal function (eGFR less than
60 mL/min/1.73 m2) was 5.0% (Table 2). The frequency of
decreased renal function was only 0.7% in participants aged
35 to 44 yr, but this figure increased to 19.8% in patients
aged 65 yr or more (p<0.05) (Table 5). The prevalence of
decreased renal function was no different according to gen-
der, with or without stratification based on age 50 yr. The
prevalence of decreased renal function was also increased in
the presence of previous cardiovascular events, hypertension,
and diabetes mellitus, as well as increased SBP, serum glu-
cose, and serum cholesterol (p<0.05). However, the preva-
lence of decreased renal function was not related to DBP or
LDL-cholesterol levels (p>0.05). 
Factors related to the prevalence of CKD
The ORs for the prevalence of CKD are listed in Table 6.
We tested the ORs of each clinical parameter with or with-
out adjustment for age, sex, BMI, hypertension, and dia-
betes mellitus, which are well known risk factors for CKD.
Without adjustment, the factors of age, previous cardiovas-
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Fig. 2. The changes of prevalence of diabetes mellitus, hyperten-
sion, and higher BMI in each age group compared to age group
less than 40 yr in both genders.
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Malecular events, hypertension, diabetes mellitus, SBP, DBP, BMI,
fasting blood glucose, serum cholesterol, and serum LDL-
cholesterol were related to the presence of CKD. 
Age, BMI, hypertension, diabetes mellitus, SBP, DBP,
and fasting blood glucose were independent factors related
to the higher prevalence of CKD after adjustment of tradi-
tional risk factors for CKD.
Patients aged 65 yr or more showed the highest risk and
had a 3.174-fold increase in risk for CKD compared to par-
ticipants less than 45 yr of age. Adjusted ORs for CKD were
1.591 for BMI less than 10th percentile (p=0.059), 1.856
for BMI 50th to 90th percentile (p<0.001), and 2.441 for
BMI 90th percentile or more (p<0.001), compared to par-
ticipants with BMIs in the 10th to 50th percentile. Diabetes
mellitus and hypertension were also related to increased ORs
for CKD. The prevalence of CKD was increased in subjects
with SBPs 130 mmHg to 139 mmHg (1.818 folds, p=0.010)
and in subjects with SBPs 140 mmHg or more (1.874 folds,
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*History of CVD: cerebrovascular disease such as coronary arterial disease and cerebrovascular accident reported by participants; BMI: less than the
10th percentile (BMI <20.7 kg/m
2), 10th to 50th percentile (BMI 20.7 to 24 kg/m
2), 50th to 90th percentile (BMI 24.1 to 28.0 kg/m
2), and greater than the
90th percentile (BMI >28.0 kg/m
2).
CVD, cerebrovascular disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Macro* No albuminuria All albuminuria Micro*
Age (yr)
35-44  764 (91.7) 69 (8.3) 57 (6.8) 12 (1.4)
45-54 696 (90.6) 72 (9.4) 60 (7.8) 12 (1.6)
55-64 387 (89.6) 45 (10.4) 37 (8.6) 8 (1.9)
65 or more 268 (83.0) 55 (17.0) 49 (15.2) 6 (1.9)
Female 1,083 (89.9) 122 (10.1) 107 (8.9) 15 (1.2)
Male 1,032 (89.7) 119 (10.3) 96 (8.3) 23 (2.0)
History of CVD*, no 2,044 (89.9) 229 (10.1) 191 (8.4) 38 (1.7)
History of CVD*, yes 57 (86.4) 9 (13.6) 9 (13.6) 0 (0.0)
Current non-smoking 1,619 (90.1) 177 (9.9) 147 (8.2) 30 (1.7)
Current smoking 482 (88.8) 61 (11.2) 53 (9.8) 8 (1.5)
BMI* 
Less than 10th percentile  212 (91.4) 20 (8.6) 18 (7.8) 2 (0.9)
10th-50th percentile 831 (93.5) 58 (6.5) 51 (5.7) 7 (0.8)
50th-90th percentile 865 (88.4) 113 (11.6) 98 (10.0) 15 (1.5)
Over 90th percentile 206 (80.5) 50 (19.5) 36 (14.1) 14 (5.5)
Diabetes mellitus, absent 1,928 (91.7) 175 (8.3) 152 (7.2) 23 (1.1)
Diabetes mellitus, present 173 (73.3) 63 (26.7) 48 (20.3) 15 (6.4)
Fasting Glucose (mg/dL)
Less than 110 1,916 (91.5) 177 (8.5) 153 (7.3) 24 (1.1)
110-125 96 (82.1) 21 (17.9) 17 (14.5) 4 (3.4)
126 or more 103 (70.5) 43 (29.5) 33 (22.6) 10 (6.8)
Hypertension, no 1,407 (93.4) 100 (6.6) 84 (5.6) 16 (1.1)
Hypertension, yes 692 (83.4) 138 (16.6) 116 (14.0) 22 (2.7)
SBP (mmHg)
Less than 110  318 (93.3) 23 (6.7) 20 (5.9) 3 (0.9)
110-119 454 (95.2) 23 (4.8) 20 (4.2) 3 (0.6)
120-129 490 (92.3) 41 (7.7) 32 (6.0) 9 (1.7)
130-139 401 (89.1) 49 (10.9) 43 (9.6) 6 (1.3)
140 or more 450 (81.1) 105 (18.9) 88 (14.5) 17 (3.1)
DBP (mmHg)
Less than 70  420 (95.2) 21 (4.8) 19 (4.3) 2 (0.5)
70-79 629 (91.8) 56 (8.2) 49 (7.2) 7 (1.0)
80-89 727 (89.8) 83 (10.2) 69 (8.5) 14 (1.7)
90 or more 337 (80.6) 81 (19.4) 66 (15.8) 15 (3.6)
Cholesterol (mg/dL)
Less than 200 1,464 (90.3) 157 (9.7) 135 (8.3) 22 (1.4)
200 or more 651 (88.6) 84 (11.4) 68 (9.3) 16 (2.2)
LDL-cholesterol (mg/dL)
Less than 100 968 (90.3) 104 (9.7) 86 (8.0) 18 (1.7)
100-119 599 (90.8) 61 (9.2) 56 (8.5) 5 (0.8)
120 or more 548 (87.8) 76 (12.2) 61 (9.8) 15 (2.4)
Table 4. The prevalence of albuminuria in adults aged 35 yr or more in urban Koreap=0.019), compared to subjects with SBPs 110 to 119 mmHg.
The adjusted OR for CKD in subjects with DBPs 90 mmHg
or more was 2.308 (p=0.002) compared to subjects with DBP
less than 70 mmHg. The prevalence of CKD in subjects with
fasting glucose levels of 126 mg/dL or more was 2.169 times
that in subjects with fasting glucose less than 110 mg/dL
(p=0.015). 
DISCUSSION
Based on the results of this study, we report the prevalence
of CKD to be 13.7% in urban Koreans, and we estimate that
3.2 million urban Koreans age 35 yr or older may have chron-
ic kidney disease. Factors such as older age, high BMI, hyper-
tension, diabetes, high blood pressures, and high fasting
blood glucose were associated with an increased prevalence
of CKD. Although the participants in this study were vol-
unteers, they were representative of the overall urban Kore-
an population age 35 yr or greater for the following reasons.
First, we matched the age, gender, and sub-district of origin
for participants to those in the general population. Second,
we only allowed one study participant per family to exclude
confounding by genetic effects. Third, almost half of Kore-
ans age 35 yr or greater live in the 7 selected cities accord-
ing to the 2006 Korean Population Census.
The prevalence of CKD differs in various ethnic groups.
In the National Health and Nutrition Examination Survey
(NHANES) III, conducted from 1988 to 1994, the preva-
lence of CKD was 11.0%, and the prevalence of decreased
renal function (eGFR less than 60 mL/min/1.73 m2) was
4.7% (19). In an Australian survey, the prevalences of CKD
and decreased renal function were 13.1% and 11.2%, respec-
tively (2). In Japan, the prevalence of decreased renal func-
tion was as high as 19.2%, with estimation of eGFR using
Japanese coefficient 0.881 (3). Among Chinese patients more
than 40 yr of age living in Beijing, the prevalences of CKD
and decreased renal function were calculated to be 12.6%
and 4.9%, respectively, based on the simplified MDRD equa-
tion (20). These findings were similar to our results (13.7%
and 5.0%). However, the simplified MDRD equation is not
easily applied in all races, especially in Asians (17). There are
modifications of the MDRD equation for Japanese and the
Chinese populations (21, 22). With support from the Kore-
an Society of Nephrology, the study is proceeding to deter-
mine if the MDRD equation is applicable in Korean patients
and to determine if a modification coefficient is needed in
the Korean equation. Hence, the eGFR in this study was
limited in its estimate of the prevalence of CKD. When we
calculated the eGFR using the Cockcroft-Gault equation
divided by the body surface area (CG/BSA), described in a
previous report by Coresh et al. (19), the overall prevalence
of CKD was 17.0% (401/2,356), and the prevalence of CKD
stage 3 or more was 8.6% (203/2,356). These figures were
higher than those obtained using the MDRD equation. Other
studies have also shown a higher prevalence of CKD using
the CG/BSA equation, compared to the MDRD equation
(23, 24). There is still debate concerning which is the more
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eGFR
≥90 
eGFR 
<60
eGFR 
60-89
Age (yr)
35-44  182 (21.8) 645 (77.4) 6 (0.7)
45-54 160 (20.8) 590 (76.8) 18 (2.3)
55-64 82 (19.0) 321 (74.3) 29 (6.7)
65 or more 11 (3.4) 248 (76.8) 64 (19.8)
Female 240 (19.9) 903 (74.9) 62 (5.1)
Male 195 (16.9) 901 (78.3) 55 (4.8)
History of CVD*, no 421 (18.5) 1,748 (76.9) 104 (4.6)
History of CVD*, yes 12 (18.2) 42 (63.6) 12 (18.2)
Current non-smoking 330 (18.4) 1,367 (76.1) 99 (5.5)
Current smoking 103 (19.0) 423 (77.9) 17 (3.1)
BMI* 
Less than 10th percentile  64 (27.6) 157 (67.7) 11 (4.7)
10th-50th percentile 173 (19.5) 688 (77.4) 28 (3.1)
50th-90th percentile 161 (16.5) 756 (77.3) 61 (6.2)
Over 90th percentile 37 (14.5) 202 (78.9) 117 (6.6)
Diabetes mellitus, absent 395 (18.8) 1,616 (76.8) 92 (4.4)
Diabetes mellitus, present 38 (16.1) 174 (73.7) 24 (10.2)
Fasting Glucose (mg/dL)
Less than 110 390 (18.6) 1,609 (76.9) 94 (4.5)
110-125 17 (14.5) 93 (79.5) 7 (6.0)
126 or more 28 (19.2) 102 (69.9) 16 (11.0)
Hypertension, no 286 (19.0) 1,175 (78.0) 46 (3.1)
Hypertension, yes 147 (17.7) 613 (73.9) 70 (8.4)
SBP (mmHg)
Less than 110  69 (20.2) 260 (76.2) 12 (3.5)
110-119 97 (20.3) 366 (76.7) 14 (2.9)
120-129 90 (16.9) 419 (78.9) 22 (4.1)
130-139 80 (17.8) 345 (76.7) 25 (5.6)
140 or more 99 (17.8) 412 (74.2) 44 (7.9)
DBP (mmHg)
Less than 70  98 (22.2) 324 (73.5) 19 (4.3)
70-79 123 (18.0) 531 (77.5) 31 (4.5)
80-89 129 (15.9) 645 (79.6) 36 (4.4)
90 or more 85 (20.3) 302 (72.2) 31 (7.4)
Cholesterol (mg/dL)
Less than 200 336 (20.7) 1,224 (75.5) 61 (3.8)
200 or more 99 (13.5) 580 (78.9) 56 (7.6)
LDL-cholesterol (mg/dL)
Less than 100 217 (20.2) 811 (75.7) 44 (4.1)
100-119 131 (19.8) 500 (75.8) 29 (4.4)
120 or more 87 (13.9) 493 (79.0) 44 (7.1)
Table 5. The prevalence of eGFR groups in adults aged 35 yr
or more in urban Korea
*History of CVD: cerebrovascular disease such as coronary arterial
disease and cerebrovascular accident reported by participants; BMI:
less than the 10th percentile (BMI <20.7 kg/m
2), 10th to 50th percentile
(BMI 20.7 to 24 kg/m
2), 50th to 90th percentile (BMI 24.1 to 28.0 kg/m
2),
and greater than the 90th percentile (BMI >28.0 kg/m
2).
eGFR, estimated glomerular filtration rate; CVD, cerebrovascular dis-
ease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure.accurate equation to estimate GFR, especially in Asian pati-
ents. Hence, we need to re-analyze this data in the near future
according to the new method of estimating GFR. The preva-
lence of CKD in subjects with routine health check-up from
a Korean tertiary hospital was 16.1% (25) higher than that
of this study because the criteria of albuminuria in that study
was defined by the result of urine dipstick test, the hema-
turia was also regarded as the sign of renal damage, and the
study population was not matched to the general population
but included from the visitors to health promotion center of
a tertiary hospital.
Advanced age is a well known risk factor for CKD, and
our study supported this finding (3, 4, 19). Individuals with-
out diabetes mellitus or hypertension, which are also inde-
pendent risk factors for CKD that increase with aging, were
more likely to have CKD and decreased renal function in old
S18 S. Kim, C.S. Lim, D.C. Han, et al.
*History of CVD: cerebrovascular disease such as coronary arterial disease and cerebrovascular accident reported by participants; BMI: less than
the 10th percentile (BMI <20.7 kg/m
2), 10th to 50th percentile (BMI 20.7 to 24 kg/m
2), 50th to 90th percentile (BMI 24.1 to 28.0 kg/m
2), and greater
than the 90th percentile (BMI >28.0 kg/m
2); 
�
Adjusted with age, gender, BMI, hypertension, and diabetes mellitus.
CKD, chronic kidney disease; OR, odds ratio; CVD, cerebrovascular disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure.
p Crude OR [95% CI] p Adjusted OR [95% CI]
�
Age (yr)
35-44 1.000 - 1.000 -
45-54 1.296 [0.932-1.801] 0.123 1.100 [0.784-1.545] 0.581
55-64 1.844 [1.291-2.634] 0.001 1.263 [0.862-1.849] 0.230
65 or more 4.669 [3.334-6.537] <0.001 3.174 [2.202-4.574] <0.001
Female 1.000 - 1.000 -
Male 0.961 [0.759-1.215] 0.737 0.887 [0.687-1.145] 0.359
History of CVD*, no 1.000 - 1.000 -
History of CVD*, yes 2.870 [1.675-4.920] <0.001 1.471 [0.818-2.645] 0.197
Current non-smoking 1.000 - 1.000 -
Current smoking 0.939 [0.707-1.246] 0.663 1.111 [0.792-1.558] 0.541
BMI* 
Less than 10th percentile  1.409 [0.885-2.243] 0.149 1.591 [0.983-2.575] 0.059
10th-50th percentile 1.000 - 1.000 -
50th-90th percentile 2.077 [1.554-2.776] <0.001 1.856 [1.372-2.510] <0.001
Over 90th percentile 3.346 [2.308-4.851] <0.001 2.441 [1.642-3.629] <0.001
Diabetes mellitus, no 1.000 - 1.000 -
Diabetes mellitus, yes 3.549 [2.617-4.814] <0.001 2.532 [1.823-3.517] <0.001
Fasting Glucose (mg/dL)
Less than 110 1.000 - 1.000 -
110-125 2.031 [1.280-3.222] 0.003 1.460 [0.892-2.390] 0.132
126 or more 4.012 [2.785-5.781] <0.001 2.169 [1.161-4.050] 0.015
Hypertension, no 1.000 - 1.000 -
Hypertension, yes 2.685 [2.112-3.413] <0.001 1.850 [1.420-2.410] <0.001
SBP (mmHg)
Less than 110  1.308 [0.792-2.158] 0.294 1.355 [0.806-2.277] 0.252
110-119 1.000 - 1.000 -
120-129 1.489 [0.957-2.316] 0.077 1.213 [0.766-1.918] 0.410
130-139 2.405 [1.570-3.685] <0.001 1.818 [1.157-2.857] 0.010
140 or more 3.786 [2.546-5.629] <0.001 1.874 [1.111-3.161] 0.019
DBP (mmHg)
Less than 70  1.000 - 1.000 -
70-79 1.363 [0.907-2.049] 0.137 1.300 [0.841-2.010] 0.238
80-89 1.667 [1.130-2.458] 0.010 1.373 [0.894-2.107] 0.148
90 or more 3.205 [2.142-4.794] <0.001 2.308 [1.366-3.900] 0.002
Cholesterol (mg/dL)
Less than 200 1.000 - 1.000 -
200 or more 1.496 [1.173-1.907] 0.001 1.270 [0.979-1.649] 0.072
LDL-cholesterol (mg/dL)
Less than 100 1.000 - 1.000 -
100-119 1.016 [0.658-1.361] 0.918 0.991 [0.725-1.354] 0.954
120 or more 1.461 [1.109-1.926] 0.007 1.308 [0.973-1.758] 0.075
Table 6. Crude and adjusted odds ratios for CKD in adults aged 35 yr or more in urban Koreaage (19). The prevalence of decreased renal function (eGFR
less than 60 mL/min/1.73 m2) was low in younger partici-
pants (0.3% in age group 35 to 44 yr, 1.1% in age group
45 to 54 yr) without diabetes or hypertension, but it was
quite high (21.1%) among subjects older than 65 yr of age
without diabetes or hypertension, similar to the NHANES
III report (19).
Male gender is known as a risk factor for ESRD (26). In
women, the cumulative incidence of ESRD remains lower
than that of men during the reproductive years, but then
increases after menopause (26). However, in many cross-sec-
tional studies, the prevalence of CKD is greater in women
than it is in men. The NHANES data showed a higher
prevalence of CKD in women (19, 27). The AusDiab study
also reported a significant gender difference (9.3% in males
and 13.0% in females) (2). In the present study, there were
no differences in the CKD prevalences between the genders.
However, male participants younger than 50 yr of age
showed a higher prevalence of CKD than females of the
same age did, and female participants 50 yr of age or more
had a higher prevalence of CKD than male participants did.
One of the possible explanations of the gender difference in
CKD prevalence according to age was that the increase rates
of the prevalence of hypertension, diabetes, and higher BMI
with aging in females were higher than in males from the
ages of 40-50 yr (Fig. 2). 
In our study, high BMI was also an independent predic-
tor of CKD, as in other studies (4, 28). High BMI was an
independent risk factor of decreased renal function (29) and
was also associated with an increased incidence of ESRD in
Japanese individuals living on Okinawa (26). In the present
study, the risk of CKD increased in participants with BMI
greater than 24 kg/m2, which means that the modest increase
in BMI could be a risk factor for renal injury in Asian popu-
lations (28, 30). This is consistent with the findings that
Asians develop cardiovascular complications at lower BMIs
compared to white individuals and that the upper limit of
normal BMI for Asians is closer to 23 kg/m2 than it is to 25
kg/m2 (31).
It is already known that factors such as hypertension (4,
19, 32), diabetes (19, 32), and blood pressure (27, 33) con-
tribute to CKD, which is also evident in this study. We con-
firmed that systolic blood pressures of 130 mmHg or more,
diastolic blood pressures of 90 mmHg or more, and fasting
blood glucose levels of 126 mg/dL or more were indepen-
dently related to the prevalence of CKD.
The present study has some limitations. First, study par-
ticipants were not randomly selected across the whole nation,
and they were mainly urbanites. This indicates a selection
bias. However, the selected participants were representative
of urban residents because they were selected in proportion
to the age and sex of the general populations in the 7 cities,
which contain approximately 50% of the Korean popula-
tion. Second, the present study was a cross-sectional design.
Therefore, we could not confirm definite causality between
CKD and its risk factors. Third, for laboratory studies, esti-
mation was based on one measurement and might have false
positive or false negative errors. CKD patients in this study
may or may not have had acute renal insufficiency. Although
the method used to measure serum creatinine in participat-
ing hospitals was the Jaffe method, the auto-analyzer mod-
els differed. We did not standardize the serum creatinine
result among hospitals. These factors could have led to over-
estimation or underestimation of the prevalence of CKD.
And, as stated above, the MDRD equation for Koreans has
not been validated and is under investigation. For this rea-
son, the CG/BSA equation was also used for estimating GFR
on supplementary analysis. 
Despite the above limitations, the present study is the first
epidemiologic study designed to survey the prevalence of
CKD in Korea. The prevalence of CKD in Korea was 13.7%,
which is similar to that seen in Chinese patients in Beijing.
The factors associated with CKD were age, BMI, diabetes
mellitus, hypertension, blood pressure, and fasting glucose.
Korea, in which the prevalence of CKD including ESRD is
increasing, should prepare a policy of early detection and
appropriate treatment for CKD patients. The present data
will be helpful in taking this action.
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al University College of Medicine (Kwon Wook Joo, Kook
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